vs

Side-by-side financial comparison of Nuvve Holding Corp. (NVVE) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

Roivant Sciences Ltd. is the larger business by last-quarter revenue ($2.0M vs $1.9M, roughly 1.0× Nuvve Holding Corp.). Nuvve Holding Corp. runs the higher net margin — -314.5% vs -13301.2%, a 12986.7% gap on every dollar of revenue. On growth, Nuvve Holding Corp. posted the faster year-over-year revenue change (7.9% vs -77.8%). Over the past eight quarters, Nuvve Holding Corp.'s revenue compounded faster (8.3% CAGR vs -73.7%).

Nuvve Holding Corp. is a global technology provider specializing in vehicle-to-grid (V2G) solutions for electric vehicles. It delivers intelligent energy management platforms that allow EV batteries to feed excess stored power back to electrical grids, serving commercial fleet operators, utility firms, and residential EV owners across North America, Europe, and Asia-Pacific.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

NVVE vs ROIV — Head-to-Head

Bigger by revenue
ROIV
ROIV
1.0× larger
ROIV
$2.0M
$1.9M
NVVE
Growing faster (revenue YoY)
NVVE
NVVE
+85.8% gap
NVVE
7.9%
-77.8%
ROIV
Higher net margin
NVVE
NVVE
12986.7% more per $
NVVE
-314.5%
-13301.2%
ROIV
Faster 2-yr revenue CAGR
NVVE
NVVE
Annualised
NVVE
8.3%
-73.7%
ROIV

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
NVVE
NVVE
ROIV
ROIV
Revenue
$1.9M
$2.0M
Net Profit
$-6.1M
$-265.9M
Gross Margin
Operating Margin
-346.7%
-16966.1%
Net Margin
-314.5%
-13301.2%
Revenue YoY
7.9%
-77.8%
Net Profit YoY
-19.0%
-257.0%
EPS (diluted)
$-69.41
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NVVE
NVVE
ROIV
ROIV
Q4 25
$1.9M
$2.0M
Q3 25
$1.6M
$1.6M
Q2 25
$2.2M
Q1 25
$934.3K
$-39.6M
Q4 24
$1.8M
$9.0M
Q3 24
$1.9M
$4.5M
Q2 24
$802.2K
$8.0M
Q1 24
$779.8K
$28.9M
Net Profit
NVVE
NVVE
ROIV
ROIV
Q4 25
$-6.1M
$-265.9M
Q3 25
$-4.5M
$-113.5M
Q2 25
$-223.4M
Q1 25
$-6.9M
$-206.5M
Q4 24
$-5.1M
$169.4M
Q3 24
$-1.6M
$-230.2M
Q2 24
$-3.9M
$95.3M
Q1 24
$-6.7M
$-151.1M
Operating Margin
NVVE
NVVE
ROIV
ROIV
Q4 25
-346.7%
-16966.1%
Q3 25
-319.7%
-19492.9%
Q2 25
-13130.0%
Q1 25
-597.9%
674.8%
Q4 24
-314.2%
-3042.6%
Q3 24
-95.8%
-7636.0%
Q2 24
-718.5%
-1279.5%
Q1 24
-929.4%
-919.5%
Net Margin
NVVE
NVVE
ROIV
ROIV
Q4 25
-314.5%
-13301.2%
Q3 25
-281.9%
-7225.9%
Q2 25
-10292.9%
Q1 25
-735.6%
521.8%
Q4 24
-285.2%
1878.3%
Q3 24
-86.0%
-5143.8%
Q2 24
-491.0%
1192.7%
Q1 24
-861.1%
-522.3%
EPS (diluted)
NVVE
NVVE
ROIV
ROIV
Q4 25
$-69.41
$-0.38
Q3 25
$-0.24
$-0.17
Q2 25
$-0.33
Q1 25
$-3.88
$-0.28
Q4 24
$-1050.64
$0.23
Q3 24
$-2.47
$-0.31
Q2 24
$-6.70
$0.12
Q1 24
$-16.89
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NVVE
NVVE
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$5.5M
$4.5B
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$-1.7M
$4.3B
Total Assets
$17.4M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NVVE
NVVE
ROIV
ROIV
Q4 25
$5.5M
$4.5B
Q3 25
$939.4K
$4.4B
Q2 25
$4.5B
Q1 25
$1.2M
$4.9B
Q4 24
$371.5K
$5.1B
Q3 24
$325.2K
$5.4B
Q2 24
$1.4M
$5.7B
Q1 24
$5.3M
$6.5B
Total Debt
NVVE
NVVE
ROIV
ROIV
Q4 25
$1.7M
Q3 25
$3.0M
Q2 25
Q1 25
$4.8M
Q4 24
$5.5M
Q3 24
$2.4M
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
NVVE
NVVE
ROIV
ROIV
Q4 25
$-1.7M
$4.3B
Q3 25
$-1.4M
$4.4B
Q2 25
$4.3B
Q1 25
$-3.2M
$4.7B
Q4 24
$-1.3M
$5.2B
Q3 24
$3.0M
$5.2B
Q2 24
$3.3M
$5.4B
Q1 24
$6.6M
$6.0B
Total Assets
NVVE
NVVE
ROIV
ROIV
Q4 25
$17.4M
$5.2B
Q3 25
$16.8M
$5.1B
Q2 25
$5.0B
Q1 25
$16.5M
$5.4B
Q4 24
$16.8M
$5.8B
Q3 24
$18.3M
$6.2B
Q2 24
$18.5M
$6.5B
Q1 24
$23.5M
$7.2B
Debt / Equity
NVVE
NVVE
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.81×
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NVVE
NVVE
ROIV
ROIV
Operating Cash FlowLast quarter
$-4.3M
$-196.5M
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
0.0%
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NVVE
NVVE
ROIV
ROIV
Q4 25
$-4.3M
$-196.5M
Q3 25
$-5.1M
$-185.7M
Q2 25
$-204.4M
Q1 25
$-1.8M
$-172.6M
Q4 24
$-3.5M
$-207.3M
Q3 24
$-3.5M
$-266.8M
Q2 24
$-4.0M
$-192.8M
Q1 24
$-4.7M
$-108.5M
Free Cash Flow
NVVE
NVVE
ROIV
ROIV
Q4 25
$-201.4M
Q3 25
$-5.1M
$-193.5M
Q2 25
$-208.4M
Q1 25
$-1.8M
$-173.4M
Q4 24
$-3.5M
$-209.1M
Q3 24
$-3.5M
$-267.8M
Q2 24
$-4.0M
$-193.8M
Q1 24
$-4.8M
$-108.8M
FCF Margin
NVVE
NVVE
ROIV
ROIV
Q4 25
-10076.0%
Q3 25
-317.6%
-12317.8%
Q2 25
-9604.5%
Q1 25
-194.9%
438.1%
Q4 24
-196.0%
-2318.5%
Q3 24
-182.9%
-5984.4%
Q2 24
-501.7%
-2425.5%
Q1 24
-611.2%
-376.1%
Capex Intensity
NVVE
NVVE
ROIV
ROIV
Q4 25
0.0%
246.9%
Q3 25
0.2%
499.6%
Q2 25
185.9%
Q1 25
1.3%
-2.0%
Q4 24
0.5%
20.3%
Q3 24
0.1%
22.3%
Q2 24
1.5%
12.1%
Q1 24
5.2%
1.2%
Cash Conversion
NVVE
NVVE
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NVVE
NVVE

Engineering Services$1.1M57%
Other$838.4K43%

ROIV
ROIV

Segment breakdown not available.

Related Comparisons